phosphatidylcholines has been researched along with nifedipine in 14 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 16,024 | 2,496 | 1,505 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mak, IT; Misik, V; Weglicki, WB | 1 |
| Amatuni, VG; Malaian, KL; Zakaharian, AK | 1 |
| Mason, RP; Moisey, DM; Shajenko, L | 1 |
| Funae, Y; Imai, Y; Imaoka, S; Shimada, T | 1 |
| Ganz, P; Seelig, J | 1 |
| Beuck, M; Fischer, H; Nowicka, G; Robenek, H; Schmitz, G | 1 |
| Gergel, D; Misík, V; Ondrias, K; Stasko, A | 1 |
| Küffer, B; Locher, R; Neyses, L; Stimpel, M; Vetter, W | 1 |
| Gergel, D; Hromadová, M; Misík, V; Ondrias, K; Stasko, A | 1 |
| Chander, A; Grunstein, MM; Sen, N | 1 |
| Kobusiewicz, W; Ledwozyw, A; Michalak, J; Ogonowska-Kobusiewicz, M | 1 |
| Chander, A; Sen, N; Spitzer, AR; Wu, AM | 1 |
| Funakoshi, Y; Itai, S; Iwao, Y; Noguchi, S | 1 |
| Arpicco, S; Cilurzo, F; Franzé, S; Marengo, A; Minghetti, P; Stella, B | 1 |
14 other study(ies) available for phosphatidylcholines and nifedipine
| Article | Year |
|---|---|
Formation of superoxide in the reaction of photolytically altered nifedipine--a nitroso compound--with unsaturated membrane lipids.
Topics: Chelating Agents; Electron Spin Resonance Spectroscopy; Fatty Acids, Unsaturated; Hydrogen Peroxide; Iron; Membrane Lipids; Nifedipine; Phosphatidylcholines; Photochemistry; Superoxides | 1992 |
[The effect of a single dose of nifedipine, intal, sodium thiosulfate and Essentiale on the blood level of calcium, hydroperoxides, thiol compounds and prostaglandins in bronchial asthma patients].
Topics: Antioxidants; Asthma; Calcium; Cromolyn Sodium; Drug Evaluation; Humans; Hydrogen Peroxide; Nifedipine; Phosphatidylcholines; Prostaglandins; Respiration; Sulfhydryl Compounds; Thiosulfates | 1992 |
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity.
Topics: Animals; Benzene Derivatives; Benzoflavones; Catalysis; Cholic Acid; Cholic Acids; Cytochrome P-450 Enzyme System; Enzyme Activation; Humans; Lidocaine; NADPH-Ferrihemoprotein Reductase; Nifedipine; Oxidation-Reduction; Phosphatidylcholines; Phosphatidylserines; Phospholipids; Rabbits; Rats; Testosterone | 1992 |
Nonclassical hydrophobic effect in membrane binding equilibria.
Topics: Amlodipine; Calorimetry; Dibucaine; Fluorescent Dyes; Lipid Bilayers; Liposomes; Membrane Lipids; Naphthalenesulfonates; Nifedipine; Phosphatidylcholines; Solubility; Tetraphenylborate; Thermodynamics; Water | 1991 |
Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages.
Topics: Animals; Cholesterol; Humans; Imidazoles; Kinetics; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mice; Nifedipine; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Sphingomyelins; Sterol Esterase; Sterol O-Acyltransferase | 1990 |
Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadine.
Topics: Anti-Arrhythmia Agents; Carbolines; Electron Spin Resonance Spectroscopy; Free Radicals; Hydrogen-Ion Concentration; In Vitro Techniques; Lipid Peroxides; Liposomes; Nifedipine; Phosphatidylcholines; Verapamil | 1989 |
The cholesterol content of the human erythrocyte influences calcium influx through the channel.
Topics: Calcium; Cholesterol; Erythrocytes; Humans; Ion Channels; Kinetics; Liposomes; Nifedipine; Nitrendipine; Phosphatidylcholines; Time Factors | 1984 |
Comparison of antioxidant properties of nifedipine and illuminated nifedipine with nitroso spin traps in low density lipoproteins and phosphatidylcholine liposomes.
Topics: Antioxidants; Electron Spin Resonance Spectroscopy; Lipid Peroxidation; Lipoproteins, LDL; Liposomes; Nifedipine; Phosphatidylcholines | 1994 |
Stimulation of lung surfactant secretion by endothelin-1 from rat alveolar type II cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Dose-Response Relationship, Drug; Endothelins; Male; Nifedipine; Phosphatidylcholines; Protein Kinase C; Pulmonary Alveoli; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley | 1994 |
The influence of nifedipine and verapamil on the ischaemia-induced changes in canine sarcolemmal membranes.
Topics: Animals; Calcium Channel Blockers; Calcium-Transporting ATPases; Cell Membrane; Dog Diseases; Dogs; Electron Transport Complex IV; Heart; Male; Membrane Proteins; Myocardial Ischemia; Myocardium; N-Acetylneuraminic Acid; Nifedipine; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Verapamil | 1995 |
Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Dose-Response Relationship, Drug; Enzyme Activation; Nifedipine; Phosphatidylcholines; Protein Kinase C; Pulmonary Alveoli; Rats | 1997 |
Lipid nanoparticles with no surfactant improve oral absorption rate of poorly water-soluble drug.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Drug Carriers; Drug Compounding; Glycine max; Male; Nanoparticles; Nifedipine; Particle Size; Phosphatidylcholines; Phosphatidylglycerols; Polysorbates; Rats; Rats, Sprague-Dawley; Solubility | 2013 |
Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration.
Topics: Administration, Cutaneous; Calcium Channel Blockers; Drug Delivery Systems; Humans; Hyaluronic Acid; Liposomes; Nifedipine; Phosphatidylcholines; Phosphatidylethanolamines; Skin; Skin Absorption | 2018 |